A new study published in Epilepsia investigates the effects of withdrawal from two common AEDs, carbamazepine (CBZ) and valproate (VPA), on the sex-hormones of male and female AED users.
The study finds that reproductive endocrine dysfunction resulting from AED use is reversible, even after years of treatment. After withdrawal from CBZ and VPA, sexual hormone levels returned to pre-treatment levels, and treatment-associated reproductive endocrine changes reversed.
Increases in serum testosterone concentration and decreases in estradiol, another sexual hormone, lead to improved sexual function for both men and women. Women who stopped using CBZ and VPA also saw a return to normal estrogen levels and decreases in body mass index (BMI).
“These findings provide further evidence of the potentially negative effects of epilepsy treatment on reproductive endocrine functions in men and women, but they also show that some of these changes may be reversible,” says Morten I. Lossius, author of the study.
Sean Wagner | Source: alphagalileo
Further information: www.blackwellpublishing.com/press/pressitem.asp?ref=1481
More articles from
Health and Medicine:
Towards Improved Immunotherapy
01.12.2008 | Elsevier
First trial in patients with a potential treatment of the incurable ALS muscle disease
01.12.2008 | VIB, the Flanders Institute for Biotechnology
Wilkins Ice Shelf under threat
01.12.2008 | Earth Sciences
A picture paints more than a petabyte of data
01.12.2008 | Physics and Astronomy
Sex life of killer fungus finally revealed
01.12.2008 | Life Sciences
Dublin to host Europe’s largest interdisciplinary science conference in 2012
28.11.2008 | Event News
28.11.2008 | Event News
The Automobile – The Transition from Energy Guzzler to Power Supplier
20.11.2008 | Event News